Prenetics Global Limited (NASDAQ: PRE) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PRENETICS GLOBAL LIMITED

Prenetics Global Limited (NASDAQ: PRE)
Listen to this Section


$20.98
+0.1450 ( +0.70% ) 324.3K

Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Market Data


Open $20.98
Previous Close $20.83
Volume 324.3K
Market Cap $354.12M
Day Range $20.25 - $21.42
52 Week Range $6.88 - $23.63
Shares Outstanding 17.00M
Change % +0.70%
Net Change ▲ 0.1450
Insider Ownership N/A
Exchange NASDAQ
SectorIndustrials
IndustryBiotechnology: Laboratory Analytical Instruments
IPO Year2022
CountryHong Kong
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 4 Jun 12, 2025

Latest News


× Before browsing our site, please accept our cookies policy